Literature DB >> 19745167

Dual pathways of carbon monoxide-mediated vasoregulation: modulation by redox mechanisms.

Brian D Lamon1, Frank F Zhang, Nitin Puri, Sergey V Brodsky, Michael S Goligorsky, Alberto Nasjletti.   

Abstract

RATIONALE: Vascular tissues produce carbon monoxide (CO) via HO-dependent and HO-independent mechanisms; the former in tandem with biliverdin and iron and the latter as a lone product. CO has been shown to function as both a vasoconstrictor and vasodilator; however, factors that dictate the vasoregulatory phenotype of this gas are unknown. <br> OBJECTIVE: We investigated whether CO-mediated vasoconstriction is mechanistically linked to enhanced reactive oxygen species production that masks vasodilatory pathways. METHODS AND <br> RESULTS: Sprague-Dawley rat interlobar and interlobular arteries were examined in terms of superoxide (O2*-) generation and vascular reactivity in the absence and presence of antioxidants. Both authentic CO and the CO-releasing molecule (CORM)-3 constricted renal arteries and increased O2*- production in a dose-dependent manner. The antioxidants tempol, ebselen, and deferoxamine inhibited CO-induced O2*- production and converted CO from constrictor to dilator. CO-induced O2*- generation was found to involve the activity of multiple oxidases including nitric oxide synthase, NADPH oxidase, xanthine oxidase, and complex IV of the mitochondrial electron chain. Furthermore, inhibition of these enzymes converted CO from constrictor to dilator. Similarly, biliverdin and bilirubin inhibited CO-induced O2*- production and vasoconstriction, allowing for a vasodilatory response to CO to be expressed. CO-induced vasoconstriction was dependent on a non-thromboxane agonist of the thromboxane receptor, whereas vasodilatory mechanisms of CO relied on the activation of soluble guanylate cyclase and calcium-gated potassium channels. <br> CONCLUSIONS: CO-induced vasoconstriction involves the generation of reactive oxygen species, which, when negated, allows for the expression of vasodilatory pathways which are masked by the primary oxidative stress response to this gas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19745167      PMCID: PMC2771695          DOI: 10.1161/CIRCRESAHA.109.197434

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

1.  Carbon monoxide promotes endothelium-dependent constriction of isolated gracilis muscle arterioles.

Authors:  Fruzsina K Johnson; Robert A Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-04-03       Impact factor: 3.619

Review 2.  Biological chemistry of carbon monoxide.

Authors:  Claude A Piantadosi
Journal:  Antioxid Redox Signal       Date:  2002-04       Impact factor: 8.401

3.  Peroxynitrite reversibly inhibits Ca(2+)-activated K(+) channels in rat cerebral artery smooth muscle cells.

Authors:  A K Brzezinska; D Gebremedhin; W M Chilian; B Kalyanaraman; S J Elliott
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-06       Impact factor: 4.733

4.  Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS.

Authors:  C Thorup; C L Jones; S S Gross; L C Moore; M S Goligorsky
Journal:  Am J Physiol       Date:  1999-12

5.  Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors.

Authors:  J I Kaide; F Zhang; Y Wei; H Jiang; C Yu; W H Wang; M Balazy; N G Abraham; A Nasjletti
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

6.  Nitric oxide synthesis influences the renal vascular response to heme oxygenase inhibition.

Authors:  Francisca Rodriguez; Fan Zhang; Sandra Dinocca; Alberto Nasjletti
Journal:  Am J Physiol Renal Physiol       Date:  2003-06

7.  Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.

Authors:  James E Clark; Patrick Naughton; Sandra Shurey; Colin J Green; Tony R Johnson; Brian E Mann; Roberta Foresti; Roberto Motterlini
Journal:  Circ Res       Date:  2003-07-03       Impact factor: 17.367

8.  Cystathionine beta-synthase as a carbon monoxide-sensitive regulator of bile excretion.

Authors:  Tsunehiro Shintani; Takuya Iwabuchi; Tomoyoshi Soga; Yuichiro Kato; Takehiro Yamamoto; Naoharu Takano; Takako Hishiki; Yuki Ueno; Satsuki Ikeda; Tadayuki Sakuragawa; Kazuo Ishikawa; Nobuhito Goda; Yuko Kitagawa; Mayumi Kajimura; Kenji Matsumoto; Makoto Suematsu
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.

Authors:  Abdulrahman K Doughan; David G Harrison; Sergey I Dikalov
Journal:  Circ Res       Date:  2007-12-20       Impact factor: 17.367

10.  Nitric oxide synthesis inhibition promotes renal production of carbon monoxide.

Authors:  Francisca Rodriguez; Brian D Lamon; Weiying Gong; Rowena Kemp; Alberto Nasjletti
Journal:  Hypertension       Date:  2003-12-29       Impact factor: 10.190

View more
  14 in total

1.  Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors.

Authors:  Jun Fang; Haibo Qin; Hideaki Nakamura; Kenji Tsukigawa; Takashi Shin; Hiroshi Maeda
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

Review 2.  Carbon monoxide as an endogenous vascular modulator.

Authors:  Charles W Leffler; Helena Parfenova; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

3.  Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.

Authors:  Susan Cheng; Asya Lyass; Joseph M Massaro; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

Review 4.  Role of carbon monoxide in kidney function: is a little carbon monoxide good for the kidney?

Authors:  Eva Csongradi; Luis A Juncos; Heather A Drummond; Trinity Vera; David E Stec
Journal:  Curr Pharm Biotechnol       Date:  2012-05       Impact factor: 2.837

5.  Enhanced hemeoxygenase activity in the rostral ventrolateral medulla mediates exaggerated hemin-evoked hypotension in the spontaneously hypertensive rat.

Authors:  Noha N Nassar; Guichu Li; Aurel L Strat; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2011-07-18       Impact factor: 4.030

6.  Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOS.

Authors:  Ali Alshehri; Marie-Pierre Bourguignon; Nicolas Clavreul; Cécile Badier-Commander; Willy Gosgnach; Serge Simonet; Christine Vayssettes-Courchay; Alex Cordi; Jean-Noël Fabiani; Tony J Verbeuren; Michel Félétou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-08       Impact factor: 3.000

7.  Characterization of a cellular denitrase activity that reverses nitration of cyclooxygenase.

Authors:  Ruba S Deeb; Tal Nuriel; Cynthia Cheung; Barbara Summers; Brian D Lamon; Steven S Gross; David P Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

Review 8.  Redox regulation of guanylate cyclase and protein kinase G in vascular responses to hypoxia.

Authors:  Boon Hwa Neo; Sharath Kandhi; Mansoor Ahmad; Michael S Wolin
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

9.  Immunohistochemical expression of fibronectin and C5b-9 in the myocardium in cases of carbon monoxide poisoning.

Authors:  Tony Fracasso; Heidi Pfeiffer; Katarzyna Michaud; Helga Köhler; Cristina Sauerland; Andreas Schmeling
Journal:  Int J Legal Med       Date:  2010-09-17       Impact factor: 2.686

10.  Antioxidants condition pleiotropic vascular responses to exogenous H(2)O(2): role of modulation of vascular TP receptors and the heme oxygenase system.

Authors:  Nitin Puri; Fan Zhang; Sumit R Monu; Komal Sodhi; Lars Bellner; Brian D Lamon; Yilun Zhang; Nader G Abraham; Alberto Nasjletti
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.